105 related articles for article (PubMed ID: 6903557)
1. Stabilization of the classical pathway C3 convertase C42, by a factor F-42, isolated from serum of patients with systemic lupus erythematosus.
Daha MR; Hazevoet HM; Vanes LA; Cats A
Immunology; 1980 Jul; 40(3):417-24. PubMed ID: 6903557
[TBL] [Abstract][Full Text] [Related]
2. Relative resistance of the F-42-stabilized classical pathway C3 convertase to inactivation by C4-binding protein.
Daha MR; van Es LA
J Immunol; 1980 Nov; 125(5):2051-4. PubMed ID: 6903579
[TBL] [Abstract][Full Text] [Related]
3. Heterogeneity, polypeptide chain composition and antigenic reactivity of autoantibodies (F-42) that are directed against the classical pathway C3 convertase of complement and isolated from sera of patients with systemic lupus erythematosus.
Daha MR; Hazevoet HM; van Es LA
Clin Exp Immunol; 1984 Jun; 56(3):614-20. PubMed ID: 6430610
[TBL] [Abstract][Full Text] [Related]
4. Regulation of immune complex-mediated complement activation by autoantibodies (F-42) isolated from sera of patients with systemic lupus erythematosus.
Daha MR; Hazevoet HM; Vanes LA
Clin Exp Immunol; 1983 Sep; 53(3):541-6. PubMed ID: 6604604
[TBL] [Abstract][Full Text] [Related]
5. Relationship between the component and regulatory proteins of the classical pathway C3 convertase.
Welch TR; Forristal J; Beischel L
J Lab Clin Med; 1986 Jun; 107(6):529-33. PubMed ID: 3635565
[TBL] [Abstract][Full Text] [Related]
6. Serum factors activating the alternative complement pathway in autoimmune disease: description of two different factors from patients with systemic lupus erythematosus.
Arroyave CM; Wilson MR; Tan EM
J Immunol; 1976 Mar; 116(3):821-6. PubMed ID: 815434
[TBL] [Abstract][Full Text] [Related]
7. Relative importance of C4 binding protein in the modulation of the classical pathway C3 convertase in patients with systemic lupus erythematosus.
Daha MR; Hazevoet HM; Hermans J; van Es LA; Cats A
Clin Exp Immunol; 1983 Oct; 54(1):248-52. PubMed ID: 6604610
[TBL] [Abstract][Full Text] [Related]
8. Epstein-Barr virus transformed B cell lines derived from patients with systemic lupus erythematosus produce a nephritic factor of the classical complement pathway.
Hiramatsu M; Tsokos GC
Clin Immunol Immunopathol; 1988 Jan; 46(1):91-9. PubMed ID: 2826058
[TBL] [Abstract][Full Text] [Related]
9. Complement fixing properties of antibodies to double-stranded DNA in systemic lupus erythematosus.
Gharavi AE; Elkon KB; Schifferli JA; Hughes GR
J Clin Lab Immunol; 1981 Nov; 6(3):251-5. PubMed ID: 7338885
[TBL] [Abstract][Full Text] [Related]
10. Complement activation by heat-killed human kidney cells: formation, activity, and stabilization of cell-bound C3 convertases.
Baker PJ; Adler S; Yang Y; Couser WG
J Immunol; 1984 Aug; 133(2):877-81. PubMed ID: 6376629
[TBL] [Abstract][Full Text] [Related]
11. Isolation of C4-binding protein from guinea pig plasma and demonstration of its function as a control protein of the classical complement pathway C3 convertase.
Burge J; Nicholson-Weller A; Austen KF
J Immunol; 1981 Jan; 126(1):232-5. PubMed ID: 6778916
[TBL] [Abstract][Full Text] [Related]
12. Characterization of the initial C3 convertase of the alternative pathway of human complement.
Fishelson Z; Pangburn MK; Müller-Eberhard HJ
J Immunol; 1984 Mar; 132(3):1430-4. PubMed ID: 6559201
[TBL] [Abstract][Full Text] [Related]
13. Modulation of complement by autoimmune antibodies isolated from sera of patients with membranoproliferative glomerulonephritis and systemic lupus erythematosus.
Daha MR; Van Es LA
Neth J Med; 1982; 25(7):202-7. PubMed ID: 6924073
[No Abstract] [Full Text] [Related]
14. Stimulation of complement amplification by F(ab')(2)-containing immune complexes and naturally occurring anti-hinge antibodies, possible role in systemic inflammation.
Lutz HU; Fumia S
Autoimmun Rev; 2008 Jun; 7(6):508-13. PubMed ID: 18558371
[TBL] [Abstract][Full Text] [Related]
15. Raji cell assay for immune complexes. Evidence for detection of Raji-directed immunoglobulin G antibody in sera from patients with systemic lupus erythematosus.
Anderson CL; Stillman WS
J Clin Invest; 1980 Aug; 66(2):353-60. PubMed ID: 6995484
[TBL] [Abstract][Full Text] [Related]
16. Modulation of the activity of the classical complement pathway C3 convertase by surface-bound C3 or C5.
Strunk RC; Giclas PC
J Immunol; 1980 Feb; 124(2):520-6. PubMed ID: 7356706
[No Abstract] [Full Text] [Related]
17. Complement activation by circulating serum factors in human glomerulonephritis.
Meri S
Clin Exp Immunol; 1985 Feb; 59(2):276-84. PubMed ID: 3919977
[TBL] [Abstract][Full Text] [Related]
18. Stabilization of homologous and heterologous cell-bound amplification convertases, C3bBb, by C3 nephritic factor.
Daha MR; Van Es LA
Immunology; 1981 May; 43(1):33-8. PubMed ID: 6166544
[TBL] [Abstract][Full Text] [Related]
19. Oxiagin from the Naja oxiana cobra venom is the first reprolysin inhibiting the classical pathway of complement.
Shoibonov BB; Osipov AV; Kryukova EV; Zinchenko AA; Lakhtin VM; Tsetlin VI; Utkin YN
Mol Immunol; 2005 Jun; 42(10):1141-53. PubMed ID: 15829304
[TBL] [Abstract][Full Text] [Related]
20. A hemolytic method for the measurement of nephritic factor.
West CD
J Immunol Methods; 2008 Jun; 335(1-2):1-7. PubMed ID: 18410942
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
